Buy & Sell Novartis AG (NVS) – Novartis AG Price Today
Aura AI Summary
Key Stats
- $293.03BMarket Cap
- HealthSector
- -13.4%3M Drawdown
- $316.87BEnterprise Value
- 3.09%Dividend Yield
- 0% Buy | 100% SellTrading Activity
- 79 daysTypical Hold Time
Novartis AG (NVS) is currently valued at a market capitalization of $293.03B, with an enterprise value of $316.87B. Over the past 52 weeks, Novartis AG has traded between a low of $104.99 and a high of $168.62, highlighting its annual price range. Over the past three months, Novartis AG has recorded a drawdown of -13.4%, reflecting recent price volatility. Novartis AG offers a dividend yield of 3.09%, with the most recent dividend of $4.77 paid on 11 Mar 26. On average, investors hold Novartis AG for approximately 79 days, indicating typical investor behavior on the platform.
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
